MedPath

Melatonin Effects in Ritalin Treated Children with Attention Deficit Hyperactivity Disorder

Not Applicable
Completed
Conditions
Attention Deficit Hyperactivity Disorder (ADHD).
Disturbance of activity and attention
Registration Number
IRCT201203167462N4
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
36
Inclusion Criteria

Age range of 7-12; ADHD combined form; Clinical need to treat with Methylphenidate; parental consent and child ascent

Exclusion criteria: any confounding co-morbiditis; any drug supplements or narcotics consumption; Children with history of major prenatal complications such as prematurity, low birth weight (reported by parents), any past or present psychosis, comorbid tourette syndrome, celiac, phenylketonuria, autism, or other persistent developmental disorders

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sleep disorders score. Timepoint: 0-2-4-8 weeks. Method of measurement: Sleep disorders scale for chilldren (SDSC).;Appetite score. Timepoint: 0-2-4-8 weeks. Method of measurement: Standard appetite questionnaire for chilldren.;Attention deficiency score and Hyperactivity score. Timepoint: 0-2-4-8 weeks. Method of measurement: ADHD rating scale for children (complited by parents).
Secondary Outcome Measures
NameTimeMethod
Stimulants side effects. Timepoint: week 8. Method of measurement: Stimulants side effects questionnare.
© Copyright 2025. All Rights Reserved by MedPath